Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Belararox Ltd. ( (AU:BRX) ) is now available.
Belararox Ltd. has reported a change in director Chris Gale’s relevant interests, disclosing the issue of 7,000,000 performance rights to an entity associated with him, Allegra Capital Pty Ltd., as approved by shareholders at the company’s 2026 extraordinary general meeting. The notice confirms Gale’s existing holdings in ordinary shares and listed options remain unchanged, while the new performance rights grant could further align his incentives with shareholder outcomes, modestly increasing potential future dilution for investors if vesting conditions are met.
The most recent analyst rating on (AU:BRX) stock is a Hold with a A$0.09 price target. To see the full list of analyst forecasts on Belararox Ltd. stock, see the AU:BRX Stock Forecast page.
More about Belararox Ltd.
Belararox Ltd. is an ASX-listed company, but this filing does not provide details on its industry, core projects or specific market focus. The document is purely a regulatory notice concerning a director’s securities holdings and related changes, without operational or strategic business information.
Average Trading Volume: 739,539
Technical Sentiment Signal: Sell
Current Market Cap: A$22.33M
For detailed information about BRX stock, go to TipRanks’ Stock Analysis page.